JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
Broad Institute
Cambridge, Estados UnidosPublicaciones en colaboración con investigadores/as de Broad Institute (4)
2013
-
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors
Cancer Discovery, Vol. 3, Núm. 12, pp. 1355-1363
-
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1 -mutant lung cancer
Cancer Discovery, Vol. 3, Núm. 8, pp. 870-879
2012
-
Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer
Clinical Cancer Research, Vol. 18, Núm. 18, pp. 4973-4985
-
Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response
Cancer Research, Vol. 72, Núm. 22, pp. 5921-5933